Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanta Seeds is a global leader in agricultural biotechnology, specializing in the research, development, and commercialization of high-performance hybrid seeds. The company utilizes advanced molecular breeding and genomic technologies to enhance crop traits such as yield, drought tolerance, and pest resistance. Its diverse portfolio features market-leading positions in sorghum, corn, sunflower, canola, and various vegetable crops. As a strategic subsidiary of UPL Limited, Advanta operates an extensive R&D network across several continents to address the challenges of climate change and food security. The company is well-known for its proprietary technology platforms, including the igrowth herbicide-tolerant sorghum. Advanta serves farmers in over 60 countries, providing sustainable solutions tailored to diverse agro-climatic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adventa Seeds.